Black Maple Capital Management’s Vigil Neuroscience VIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-215,992
Closed -$1.72M 125
2025
Q2
$1.72M Buy
+215,992
New +$968K 0.77% 22

Other funds holding VIGL

Black Maple Capital Management's VIGL Position: Q3 2025 in Review

Black Maple Capital Management sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 215,992 shares — an estimated $1.72M sold.

Black Maple Capital Management first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $1.72M in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

  • Black Maple Capital Management reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
  • Black Maple Capital Management sold 215,992 Vigil Neuroscience shares in Q3 2025, an estimated $1.72M.
  • Black Maple Capital Management first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
  • Black Maple Capital Management's Vigil Neuroscience position peaked at $1.72M in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Black Maple Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.